| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Maze Therapeutics, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 150,000 | 02 Mar 2026 | Direct | ||
| Maze Therapeutics, Inc. | Chief Executive Officer, Director | Restricted Stock Units | 75,000 | 02 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | 02 Mar 2026 | 2 | $0 | 4 | Chief Executive Officer, Director | 03 Mar 2026, 16:17 |
| MAZE | Maze Therapeutics, Inc. | 22 Sep 2025 | 1 | $0 | 4 | Chief Executive Officer, Director | 24 Sep 2025, 16:25 |
| MAZE | Maze Therapeutics, Inc. | 30 Jan 2025 | 0 | $0 | 3 | Chief Executive Officer, Director | 30 Jan 2025, 16:17 |